The goal of this observational study is to better understand real-world use of vimseltinib, treatment patterns, and health-related quality of life in participants treated with vimseltinib for TGCT.
This study will collect data in an observational disease registry involving no intervention to the participants and will not influence standard medical care or impact treatment decisions for participants.
Diagnosis of TGCT according to medical records
Prescribed vimseltinib per the approved label requirements, OR The decision to receive vimseltinib has been made but treatment has not yet been initiated.
Has provided informed consent and medical records release
None
Participants being treated for TGCT with vimseltinib in the community setting.
Cohort
Prospective
Not listed
Duration of Vimseltinib Treatment
Time to Discontinuation of Vimseltinib
Click on the lead sponsor to view all of their trials.
